Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Victor J Hruby

Showing results (221-230 of 238) with videos related to

Pageof 24
Sort By:
ACS Medicinal Chemistry Letters|September 16, 2014
Novel cyclic biphalin analogue with improved antinociceptive propertiesAdriano Mollica, Alfonso Carotenuto, Ettore Novellino, et al.
Journal of Medicinal Chemistry|October 15, 2015
Discovery of Novel Multifunctional Ligands with μ/δ Opioid Agonist/Neurokinin-1 (NK1) Antagonist Activities for the Treatment of PainAswini Kumar Giri, Christopher R Apostol, Yue Wang, et al.
Molecular Cancer Therapeutics|September 4, 2008
Gene expression profiling-based identification of cell-surface targets for developing multimeric ligands in pancreatic cancerYoganand Balagurunathan, David L Morse, Galen Hostetter, et al.
Journal of Medicinal Chemistry|February 13, 2008
A structure-activity relationship study and combinatorial synthetic approach of C-terminal modified bifunctional peptides that are delta/mu opioid receptor agonists and neurokinin 1 receptor antagonistsTakashi Yamamoto, Padma Nair, Josef Vagner, et al.
Molecules (Basel, Switzerland)|January 11, 2025
Design, Structure-Activity Relationships, and Computational Modeling Studies of a Series of α-Helix Biased, Ultra-Short Glucagon-like Peptide-1 Receptor AgonistsJonathon R Sawyer, Joseph A Audie, Jon Swanson, et al.
The AAPS Journal|October 10, 2006
New paradigms and tools in drug design for pain and addictionVictor J Hruby, Frank Porreca, Henry I Yamamura, et al.
Journal of the American Chemical Society|April 19, 2014
Discovery of amphipathic dynorphin A analogues to inhibit the neuroexcitatory effects of dynorphin A through bradykinin receptors in the spinal cordYeon Sun Lee, Dhanasekaran Muthu, Sara M Hall, et al.
Molecular Pharmaceutics|December 30, 2015
Tumor Targeting and Pharmacokinetics of a Near-Infrared Fluorescent-Labeled δ-Opioid Receptor Antagonist Agent, Dmt-Tic-Cy5Amanda Shanks Huynh, Veronica Estrella, Valerie E Stark, et al.
Journal of the American Chemical Society|April 14, 2005
Glycopeptides related to beta-endorphin adopt helical amphipathic conformations in the presence of lipid bilayersMuthu Dhanasekaran, Michael M Palian, Isabel Alves, et al.
Journal of Medicinal Chemistry|July 19, 2013
Development and in vivo quantitative magnetic resonance imaging of polymer micelles targeted to the melanocortin 1 receptorNatalie M Barkey, Christian Preihs, Heather H Cornnell, et al.
Pageof 24

Showing results (221-230 of 238) with videos related to

Sort By:
Pageof 24
ACS Medicinal Chemistry Letters|September 16, 2014
Novel cyclic biphalin analogue with improved antinociceptive propertiesAdriano Mollica, Alfonso Carotenuto, Ettore Novellino, et al.
Journal of Medicinal Chemistry|October 15, 2015
Discovery of Novel Multifunctional Ligands with μ/δ Opioid Agonist/Neurokinin-1 (NK1) Antagonist Activities for the Treatment of PainAswini Kumar Giri, Christopher R Apostol, Yue Wang, et al.
Molecular Cancer Therapeutics|September 4, 2008
Gene expression profiling-based identification of cell-surface targets for developing multimeric ligands in pancreatic cancerYoganand Balagurunathan, David L Morse, Galen Hostetter, et al.
Journal of Medicinal Chemistry|February 13, 2008
A structure-activity relationship study and combinatorial synthetic approach of C-terminal modified bifunctional peptides that are delta/mu opioid receptor agonists and neurokinin 1 receptor antagonistsTakashi Yamamoto, Padma Nair, Josef Vagner, et al.
Molecules (Basel, Switzerland)|January 11, 2025
Design, Structure-Activity Relationships, and Computational Modeling Studies of a Series of α-Helix Biased, Ultra-Short Glucagon-like Peptide-1 Receptor AgonistsJonathon R Sawyer, Joseph A Audie, Jon Swanson, et al.
The AAPS Journal|October 10, 2006
New paradigms and tools in drug design for pain and addictionVictor J Hruby, Frank Porreca, Henry I Yamamura, et al.
Journal of the American Chemical Society|April 19, 2014
Discovery of amphipathic dynorphin A analogues to inhibit the neuroexcitatory effects of dynorphin A through bradykinin receptors in the spinal cordYeon Sun Lee, Dhanasekaran Muthu, Sara M Hall, et al.
Molecular Pharmaceutics|December 30, 2015
Tumor Targeting and Pharmacokinetics of a Near-Infrared Fluorescent-Labeled δ-Opioid Receptor Antagonist Agent, Dmt-Tic-Cy5Amanda Shanks Huynh, Veronica Estrella, Valerie E Stark, et al.
Journal of the American Chemical Society|April 14, 2005
Glycopeptides related to beta-endorphin adopt helical amphipathic conformations in the presence of lipid bilayersMuthu Dhanasekaran, Michael M Palian, Isabel Alves, et al.
Journal of Medicinal Chemistry|July 19, 2013
Development and in vivo quantitative magnetic resonance imaging of polymer micelles targeted to the melanocortin 1 receptorNatalie M Barkey, Christian Preihs, Heather H Cornnell, et al.
Pageof 24